Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Melasma Tx
National Report - Results of the community-based Prospective Investigation Gauging Melasma Reduction with a New Treatment (PIGMENT Trial) reinforce the conclusion that the fixed triple-combination cream containing fluocinolone acetonide 0.01 percent, hydroquinone 4.0 percent, and tretinoin 0.05 percent (Tri-Luma Cream) is a safe and highly effective treatment for melasma. In addition, the study findings show improvement occurs quickly, extends to patients of all skin types managed in the setting of usual clinical practice, and is associated with significant improvement in quality of life, said Helen M. Torok, M.D.
Related Videos
Related Content
